Delivery Order SPE2DE21D7001-SPE2D624F5LU2
Award Date
7/23/24
Potential Completion Date
7/26/24
Potential Value
$2.9K
Federal Agency
Medical Supply Chain
Awardee
Medtronic Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Fridley, MN 55432, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
The U.S. government agency the Defense Health Agency (DHA) awarded a $2,875.65 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical products. This contract does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies. As a major supplier...
This federal contract award, valued at $2,875.65, was issued by the Defense Health Agency (DHA) to Medtronic Inc., a global leader in medical technology, through its Medtronic USA, Inc. division. The contract is for the supply of a Biologics - DBM-TS-OTI Grafton DBM Matrix product, which is a surgical implant used in various medical procedures. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of June 12, 2024. Medtronic is the prime...
The U.S. government has awarded a $3,790.50 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF medical products. This contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense. The contract has no set-aside designation and runs through July 10, 2024. Medtronic is a global leader in medical technology, providing a wide range of innovative medical devices and...
This federal contract award was issued by the Defense Health Agency (DHA), an agency within the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,274.30 fixed-price contract with economic price adjustment is for the delivery of BIOLOGICS - DBM-TS-GRAFTON DBF medical products, which are likely specialized surgical implants or biologics used in the treatment of military personnel and veterans. The contract does not have a set-aside designation and is...
Medtronic Inc., a global medical technology company, has been awarded a Delivery Order contract by the Defense Logistics Agency Troop Support Medical valued at $2,875.65. The contract is for the provision of Biologics - DBM-TS-OTI Grafton DBM Matrix, a surgical implant product. This order is not designated as a set-aside contract. The contract has a completion date of February 8, 2024 and was awarded on February 5, 2024. Medtronic Inc. has a long history of supplying medical devices and...
The U.S. government agency, the Defense Health Agency (DHA), awarded a $1,516.20 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, to provide biologics - DBM-TS-GRAFTON DBF. This contract has an ultimate completion date of October 15, 2024. Medtronic is a global medical technology company that specializes in developing and manufacturing innovative medical devices and therapies. The company has a significant...
This federal contract award, valued at $5,702.85, was issued by the Defense Health Agency (DHA) to the prime contractor Medtronic Inc. The contract is a fixed-price delivery order with an economic price adjustment, and the ultimate completion date is January 28, 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Medtronic Inc., a global leader in medical technology, will provide biologics - specifically, a Grafton DBM Matrix -...
This federal contract award, with an ID of SPE2DE21D7001|SPE2D625F10G7, was issued by the Defense Health Agency (DHA) to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,875.65 fixed-price contract, with economic price adjustment, is for the delivery of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical supplies. Medtronic is a global leader in medical technology, specializing in innovative medical devices and therapies. As a major supplier to the federal government, Medtronic...
This federal contract award, with ID SPE2DE21D7001|SPE2D625F7032, was made by the Defense Health Agency (DHA), a component of the Department of Defense, to Medtronic Inc. through its Medtronic USA, Inc. division. The contract, valued at $2,875.65, is for the delivery of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX products. This is a fixed-price delivery order contract with economic price adjustment, with an ultimate completion date of October 18, 2024. Medtronic Inc., a global leader in medical...